Cargando…

Development of a Forced Degradation Profile of Alosetron by Single Mode Reversed-Phase HPLC, LC-MS, and its Validation

Determination of alosetron in the presence of its degradation products was studied and validated by a novel HPLC method. The separation of the drug and its degradation products was achieved with the Jones Chromatography C(18) analytical column (150 mm x 4.6 mm; 3 µm) with a stationary phase in isocr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Karthik, Yamjala, Babu, Basuvan, Meyyanathan, Subramania Nainar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Austrian Journal of Pharmaceutical Sciences 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4727810/ https://www.ncbi.nlm.nih.gov/pubmed/26839817 http://dx.doi.org/10.3797/scipharm.1411-07

Ejemplares similares

Characterization of the Oxidative Degradation Product of Darunavir by LC-MS/MS
por: Yamjala, Karthik, et al.
Publicado: (2015)

Development and Validation of a HPLC and an UV Spectrophotometric Methods for Determination of Dexibuprofen in Pharmaceutical Preparations
por: Muralidharan, Selvadurai, et al.
Publicado: (2011)

A simple sensitive UFLC-MS/MS method for the simultaneous quantification of artesunate, dihydroartemisinin and quercetin in rat plasma and its application to pharmacokinetic studies
por: Puttappa, Nethravathi, et al.
Publicado: (2019)

Study of forced degradation behavior of pramlintide acetate by HPLC and LC–MS
por: Yuan, Yu, et al.
Publicado: (2017)

Determination of deflazacort in human plasma by liquid chromatography-mass spectrometry after liquid-liquid extraction and its application in human pharmacokinetics studies
por: Selvadurai, Muralidharan, et al.
Publicado: (2011)

Identification of Forced Degradation Products of Itopride by LC-PDA and LC-MS
por: Joshi, Payal, et al.
Publicado: (2011)

Forced Degradation Behaviour of Fluphenazine Hydrochloride by LC and Characterization of its Oxidative Degradation Product by LC–MS/MS
por: Thummar, Kashyap N., et al.
Publicado: (2015)

Characterization of forced degradation products of toloxatone by LC-ESI-MS/MS
por: Skibiński, Robert, et al.
Publicado: (2018)

Kinetics and Characterization of Degradation Products of Dihydralazine and Hydrochlorothiazide in Binary Mixture by HPLC-UV, LC-DAD and LC–MS Methods
por: Gumieniczek, Anna, et al.
Publicado: (2018)

Sensitive and accurate estimation of losartan potassium formulation by high-performance thin-layer chromatography
por: Selvadurai, Muralidharan, et al.
Publicado: (2011)

A Validated RP-HPLC Method for Simultaneous Estimation of Nebivolol and Hydrochlorothiazide in Tablets
por: Meyyanathan, S. N., et al.
Publicado: (2008)

LC, MS(n) and LC–MS/MS studies for the characterization of degradation products of amlodipine
por: Tiwari, Ravi N., et al.
Publicado: (2015)

Unique Quality by Design Approach for Developing HPLC and LC-MS Method for Estimation of Process and Degradation Impurities in Pibrentasvir, Antiviral Agent for Hepatitis C
por: Vemuri, Divya Kumar, et al.
Publicado: (2022)

LC and LC–MS/MS studies for the identification and characterization of degradation products of acebutolol
por: Rakibe, Uday, et al.
Publicado: (2018)

Multivariate Chemometric Comparison of Forced Degradation and Electrochemical Oxidation LC–MS Profiles of Maraviroc
por: Wroński, Michał, et al.
Publicado: (2023)

Determination of Cefixime by a Validated Stability-Indicating HPLC Method and Identification of its Related Substances by LC-MS/MS Studies
por: Talebpour, Zahra, et al.
Publicado: (2013)

Anti-inflammatory effects of alosetron mediated through 5-HT(3) receptors on experimental colitis
por: Motavallian, Azadeh, et al.
Publicado: (2019)

Development of the Validated Stability-Indicating Method for the Determination of Vortioxetine in Bulk and Pharmaceutical Formulation by HPLC-DAD, Stress Degradation Kinetics Studies and Detection of Degradation Products by LC-ESI-QTOF-MS
por: Wróblewski, Karol, et al.
Publicado: (2022)

Simultaneous determination of mometasone furoate and calcipotriol in a binary mixture by validated HPLC and chemometric-assisted UV spectrophotometric methods and identification of degradation products by LC-MS
por: Jahani, Maryam, et al.
Publicado: (2023)

HPLC-MS/MS Method for the Measurement of Insecticide Degradates in Baby Food
por: Radford, Samantha A., et al.
Publicado: (2014)

Quantitation of cyclic dinucleotides by reversed-phase LC-MS/MS
por: Spangler, Christian, et al.
Publicado: (2009)

LC–UV and LC–MS evaluation of stress degradation behavior of desvenlafaxine
por: Pawar, Shubhangi M., et al.
Publicado: (2012)

Identification of degradation impurity of TGR5 receptor agonist-ZY12201 by LC–MS technique during force degradation study
por: Sojitra, Chandrakant, et al.
Publicado: (2021)

Development Rapid Analytical Methods for Inositol as a Trace Component by HPLC and LC-MS/MS in Infant Formula
por: Shin, Jin-Ho, et al.
Publicado: (2015)

Development and Validation of an HPLC-MS/MS Method for the Early Diagnosis of Aspergillosis
por: Cerqueira, Letícia B., et al.
Publicado: (2014)

Regional brain activation during rectal distention and attenuation with alosetron in a nonhuman primate model of irritable bowel syndrome
por: Fujii, Rintaro, et al.
Publicado: (2022)

Chemical Profiling of an Antimigraine Herbal Preparation, Tianshu Capsule, Based on the Combination of HPLC, LC-DAD-MS(n), and LC-DAD-ESI-IT-TOF/MS Analyses
por: Liang, Juanjuan, et al.
Publicado: (2014)

Quantification of 17-desacetyl norgestimate in human plasma by liquid chromatography–tandem mass spectrometry (LC–MS/MS) and its application to bioequivalence study
por: Saxena, Ashish, et al.
Publicado: (2015)

Degradation Pathway for Eplerenone by Validated Stability Indicating UP-LC Method
por: Sudhakar Babu, Kondru, et al.
Publicado: (2012)

Development and validation of Lenalidomide in human plasma by LC-MS/MS
por: Ranganathan, Premanand, et al.
Publicado: (2019)

The LC-QTOF-MS/MS analysis of acid degradation products of Rifaximin, an antibiotic
por: Yaseen, Saima Baig, et al.
Publicado: (2022)

Simultaneous Identification and Quantification of Canrenone and 11-α-Hydroxy-Canrenone by LC-MS and HPLC-UVD
por: Huang, Da-Ming, et al.
Publicado: (2011)

Comparative Analysis of the Bufonis Venenum by Using TLC, HPLC, and LC-MS for Different Extraction Methods
por: Lee, Hyo-Jae, et al.
Publicado: (2012)

The degradation of levofloxacin in infusions exposed to daylight with an identification of a degradation product with HPLC-MS
por: Czyrski, Andrzej, et al.
Publicado: (2019)

Method Development and Validation of Montelukast in Human Plasma by HPLC Coupled with ESI-MS/MS: Application to a Bioequivalence Study
por: Challa, Balasekhara Reddy, et al.
Publicado: (2010)

Development of Validated and Stability-Indicating LC-DAD and LC-MS/MS Methods for Determination of Avanafil in Pharmaceutical Preparations and Identification of a Novel Degradation Product by LCMS-IT-TOF
por: CAN, Nafiz Öncü
Publicado: (2018)

Forced Degradation Studies and Development and Validation of HPLC-UV Method for the Analysis of Velpatasvir Copovidone Solid Dispersion
por: Zaman, Bakht, et al.
Publicado: (2022)

Randomised clinical trial: alosetron improves quality of life and reduces restriction of daily activities in women with severe diarrhoea-predominant IBS
por: Cremonini, F, et al.
Publicado: (2012)

Development and validation of an HPLC–MS/MS method to determine clopidogrel in human plasma
por: Liu, Gangyi, et al.
Publicado: (2016)

Identification and Characterization of Hydrolytic Degradation Products of Cefditoren Pivoxil using LC and LC-MS/TOF
por: Gawande, V. T., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_0a30d3dgsu6prs8drkaf31iu3h